Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03155672 · ClinicalTrials.gov registry record
A Phase I, Single-center, Mixed Methods Study ON THE Health Outcomes OF Visual Self Expression
A clinical trial of A Healthcare Professional, a Patient or Caregiver in the Radiation Oncology Department at the University of Pennsylvania, sponsored by Abramson Cancer Center at Penn Medicine.
- Completed
- Registry status
- 80
- Enrollment target
- 1
- Study location
NCT03155672: Completed study of A Healthcare Professional, a Patient or Caregiver in the Radiation Oncology Department at the University of Pennsylvania, sponsored by Abramson Cancer Center at Penn Medicine.
NCT03155672 is a study of A Healthcare Professional, a Patient or Caregiver in the Radiation Oncology Department at the University of Pennsylvania that has completed, run by Abramson Cancer Center at Penn Medicine. The registered enrollment target is 80 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03155672, a study of A Healthcare Professional, a Patient or Caregiver in the Radiation Oncology Department at the University of Pennsylvania, has completed, sponsored by Abramson Cancer Center at Penn Medicine.
- COMPLETED
- Registry status
- 80 participants
- Enrollment target
- 1
- Study location
Study Summary
To gain understanding about the impact of visual art making on biomarkers, such as cortisol, alpha amylase, oxytocin, etc. to examine whether and to what extent there are changes in levels of stress and immune function in patients and caregivers adults (including family caregivers and medical professionals)
Conditions Studied
Interventions
- BEHAVIORAL Art therapy
Study Locations (1)
Pennsylvania
- Abramson Cancer Center of the University of Pennsylvania - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2017-05-15 |
| Est. Completion | 2019-12-31 |
What the finished NCT03155672 record still lists
NCT03155672 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 80 participants, a relatively small participant target.
The record links to 1 condition, with A Healthcare Professional, a Patient or Caregiver in the Radiation Oncology Department at the University of Pennsylvania appearing as the primary indexed condition, and to 1 intervention - of which Art therapy is the first listed.
NCT03155672 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT03155672 about?
NCT03155672 is a clinical study titled "A Phase I, Single-center, Mixed Methods Study ON THE Health Outcomes OF Visual Self Expression". To gain understanding about the impact of visual art making on biomarkers, such as cortisol, alpha amylase, oxytocin, etc. to examine whether and to what extent there are changes in levels of stress and immune function in patients and caregivers adults (including family caregivers and medical profes...
What is the current status of trial NCT03155672?
This trial is currently completed. The enrollment target is 80 participants. The study started on 2017-05-15. Estimated completion is 2019-12-31.
What conditions does trial NCT03155672 study?
This clinical trial studies the following conditions: A Healthcare Professional, a Patient or Caregiver in the Radiation Oncology Department at the University of Pennsylvania.
What interventions are being tested in trial NCT03155672?
The interventions under investigation include: Art therapy (BEHAVIORAL).
Who is sponsoring clinical trial NCT03155672?
This trial is sponsored by Abramson Cancer Center at Penn Medicine, which has 402 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03155672 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01243931 · 80 participants · NA
Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy
- NCT01659203 · 80 participants · Phase 1
Proton or Photon RT for Retroperitoneal Sarcomas
- NCT01803451 · 80 participants · Early Phase 1
Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass
- NCT01964859 · 80 participants · Phase 2
Feasibility Study for Fibroblast Autologous Skin Grafts
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI